Compare KMDA & FAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMDA | FAC |
|---|---|---|
| Founded | 1990 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 460.3M | 497.7M |
| IPO Year | 2013 | 2025 |
| Metric | KMDA | FAC |
|---|---|---|
| Price | $7.96 | $4.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $13.50 | $13.00 |
| AVG Volume (30 Days) | 68.9K | ★ 233.9K |
| Earning Date | 11-09-2026 | 11-10-2026 |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.50 | N/A |
| Revenue Next Year | $12.63 | N/A |
| P/E Ratio | $24.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.55 | $3.98 |
| 52 Week High | $9.35 | $15.40 |
| Indicator | KMDA | FAC |
|---|---|---|
| Relative Strength Index (RSI) | 49.04 | 36.35 |
| Support Level | $6.94 | $4.27 |
| Resistance Level | $8.05 | $6.24 |
| Average True Range (ATR) | 0.20 | 0.31 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 75.38 | 30.92 |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Factorial Energy Inc is an American solid-state battery innovator backed by In-Q-Tel - the not-for-profit strategic investor for the U.S. national security community and America's allies - and Mercedes-Benz, Stellantis, Hyundai, and Kia. Through its proprietary FEST and Solstice platforms, engineered for scalable manufacturing, it delivers industry performance across defense, space, and energy storage applications. Mercedes-Benz's real-world road testing in a lightly modified test vehicle achieved over 1,200 km of range on a single charge, while Stellantis-lab testing verified 77 Ah cells demonstrating high energy density, fast-charging, and robust use for energy and power performance across temperature extremes.